Stock Information
Natera, Inc. (NTRA)
Ticker Symbol: NTRA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $45,994.96 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -1.37
Revenue (TTM): $18.89 M
Dividend Yield: N/A
ROE: -11.73%
Latest News
-
What Could Natera (NTRA) Gain From Its New Colorectal Cancer Trial Collaboration?
Sat, Nov 21, 2026 11:07 AM
-
Allogene Therapeutics to Host Events at American Society of Hematology Annual Meeting 2026 Highlighting the Potential of Allogeneic CAR T to Expand Patient Access
Fri, Nov 20, 2026 1:00 PM
-
Stanley Druckenmiller dumps Google stock in a bid to ‘not lose money’ as the outlook darkens. Here’s what he’s buying
Fri, Nov 20, 2026 12:15 PM
-
Natera vs. Tempus AI: Which Blood Test Pioneer Has the Better Stock Buy for 2027?
Thu, Nov 19, 2026 7:40 PM
-
Billionaire Stanley Druckenmiller’s New AI Warning and Top 5 Stock Picks
Thu, Nov 19, 2026 2:17 PM
-
Allspring Mid Cap Growth Fund Q3 2026 Contributors And Detractors
Thu, Nov 19, 2026 12:25 PM
-
What's Going To Happen With Tempus AI Stock Soon?
Thu, Nov 19, 2026 11:34 AM
-
What Explains Natera Stock's Nearly 10% Drop?
Wed, Nov 18, 2026 11:48 PM
-
BillionToOne Faces Short Report Alleging Kickbacks, Flawed Diagnostic Tests
Wed, Nov 18, 2026 1:53 PM
-
Alger Capital Appreciation Fund Q3 2026 Portfolio Activity
Wed, Nov 18, 2026 10:04 AM
Key Financials
Financial data not available